Aacr.org July 16, 2026 • 05:01

A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses - American Association for Cancer Research (AACR)

After a median follow-up of 16.5 months, none of the participants developed pancreatic cancer, and some of the precancerous lesions shrank or stopped growing.

Read Full Article on Original Site ↗ ← Back to News List

A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses - American Association for Cancer Research (AACR)

More from Aacr.org

Jokes about losing weight from explosive diarrhea underline an unhealthy obsession with thinness - CNN

Mom, 27, Needs to Use Medication and Defibrillator for Life After Taking Painkiller Supplement Bought at a Gas Station - Yahoo News Canada

2 adults contract measles in Ashtabula County — what’s being done to stop spread - FOX 8 News

The Best Fruit for Your Gut Health, According to a Gastroenterologist - AOL.com